BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 9664145)

  • 1. Thermosensitive liposomal taxol formulation: heat-mediated targeted drug delivery in murine melanoma.
    Sharma D; Chelvi TP; Kaur J; Ralhan R
    Melanoma Res; 1998 Jun; 8(3):240-4. PubMed ID: 9664145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy.
    Sharma D; Chelvi TP; Kaur J; Chakravorty K; De TK; Maitra A; Ralhan R
    Oncol Res; 1996; 8(7-8):281-6. PubMed ID: 8938791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated melphalan in murine tumors.
    Chelvi TP; Jain SK; Ralhan R
    Oncol Res; 1995; 7(7-8):393-8. PubMed ID: 8747602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat-mediated selective delivery of liposome-associated melphalan in murine melanoma.
    Chelvi PT; Jain SK; Ralhan R
    Melanoma Res; 1995 Oct; 5(5):321-6. PubMed ID: 8541722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthermia potentiates antitumor effect of thermosensitive-liposome-encapsulated melphalan and radiation in murine melanoma.
    Chelvi TP; Ralhan R
    Tumour Biol; 1997; 18(4):250-60. PubMed ID: 9218010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.
    Crosasso P; Ceruti M; Brusa P; Arpicco S; Dosio F; Cattel L
    J Control Release; 2000 Jan; 63(1-2):19-30. PubMed ID: 10640577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel taxol formulations: preparation and characterization of taxol-containing liposomes.
    Sharma A; Straubinger RM
    Pharm Res; 1994 Jun; 11(6):889-96. PubMed ID: 7937531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Taxol formulations: Taxol-containing liposomes.
    Straubinger RM; Sharma A; Murray M; Mayhew E
    J Natl Cancer Inst Monogr; 1993; (15):69-78. PubMed ID: 7912532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryotoxicity of free and liposome-encapsulated taxol in the chick.
    Scialli AR; DeSesso JM; Rahman A; Husain SR; Goeringer GC
    Pharmacology; 1995 Sep; 51(3):145-51. PubMed ID: 7501699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
    Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
    J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing of thermosensitive liposomes from natural lipids for multimodality cancer therapy.
    Chelvi TP; Ralhan R
    Int J Hyperthermia; 1995; 11(5):685-95. PubMed ID: 7594819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia.
    Sharma A; Sharma US; Straubinger RM
    Cancer Lett; 1996 Oct; 107(2):265-72. PubMed ID: 8947523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of paclitaxel-containing liposomes.
    Holvoet C; Vander Heyden Y; Lories G; Plaizier-Vercammen J
    Pharmazie; 2007 Feb; 62(2):126-32. PubMed ID: 17341033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.
    Kim SC; Kim DW; Shim YH; Bang JS; Oh HS; Wan Kim S; Seo MH
    J Control Release; 2001 May; 72(1-3):191-202. PubMed ID: 11389998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model.
    Sharma A; Mayhew E; Straubinger RM
    Cancer Res; 1993 Dec; 53(24):5877-81. PubMed ID: 7903197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib.
    Korani M; Nikoofal-Sahlabadi S; Nikpoor AR; Ghaffari S; Attar H; Mashreghi M; Jaafari MR
    Anticancer Agents Med Chem; 2020; 20(6):700-708. PubMed ID: 31893998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel.
    Ceruti M; Crosasso P; Brusa P; Arpicco S; Dosio F; Cattel L
    J Control Release; 2000 Jan; 63(1-2):141-53. PubMed ID: 10640588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility and therapeutic evaluation of magnetic liposomes designed for self-controlled cancer hyperthermia and chemotherapy.
    Gogoi M; Jaiswal MK; Sarma HD; Bahadur D; Banerjee R
    Integr Biol (Camb); 2017 Jun; 9(6):555-565. PubMed ID: 28513646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome formulation of paclitaxel with enhanced solubility and stability.
    Yang T; Cui FD; Choi MK; Lin H; Chung SJ; Shim CK; Kim DD
    Drug Deliv; 2007 Jul; 14(5):301-8. PubMed ID: 17613018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.